{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:22:22Z","timestamp":1786969342101,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.abd.2023.01.006","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T09:15:15Z","timestamp":1693386915000},"page":"53-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-4190","authenticated-orcid":false,"given":"Melissa de Almeida Corr\u00eaa","family":"Alfredo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7975-2429","authenticated-orcid":false,"given":"Juliano Vilaverde","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-734X","authenticated-orcid":false,"given":"Anna Carolina","family":"Miola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-1531","authenticated-orcid":false,"given":"Simone de P\u00e1dua","family":"Milagres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-6601","authenticated-orcid":false,"given":"Joel Carlos","family":"Lastoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2023.01.006_bib0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.abd.2021.08.006","article-title":"Leprosy: clinical and immunopathological characteristics","volume":"97","author":"Froes","year":"2022","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2023.01.006_bib0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.actatropica.2018.02.026","article-title":"Erythema nodosum leprosum: update and challenges on the treatment of a neglected condition","volume":"183","author":"Costa","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.abd.2023.01.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008678","article-title":"Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: a five-year retrospective analysis from a leprosy referral centre in India","volume":"14","author":"Upputuri","year":"2020","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.abd.2023.01.006_bib0020","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/S0049-3848(16)30103-7","article-title":"Update of thrombosis in multiple myeloma","volume":"140","author":"Leebeek","year":"2016","journal-title":"Thromb Res."},{"key":"10.1016\/j.abd.2023.01.006_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/1545109712455460","article-title":"Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature","volume":"11","author":"Hodowanec","year":"2012","journal-title":"J Int Assoc Physicians AIDS Care (Chic)."},{"key":"10.1016\/j.abd.2023.01.006_bib0030","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1346-8138.2011.01484.x","article-title":"Deep venous thrombosis and pulmonary embolism secondary to co-administration of thalidomide and oral corticosteroid in a patient with leprosy","volume":"39","author":"Yamaguchi","year":"2012","journal-title":"J Dermatol."},{"key":"10.1016\/j.abd.2023.01.006_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0037-8682-0385-2018","article-title":"Adverse events in patients with leprosy on treatment with thalidomide","volume":"52","author":"Drummond","year":"2019","journal-title":"Rev Soc Bras Med Trop."},{"key":"10.1016\/j.abd.2023.01.006_bib0040","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood.V98.5.1614","article-title":"Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy","volume":"98","author":"Zangari","year":"2001","journal-title":"Blood."},{"key":"10.1016\/j.abd.2023.01.006_bib0045","article-title":"Deep venous thrombosis in patients with erythema nodosum leprosum in the use of thalidomide and systemic corticosteroid in reference service in Belo Horizonte, Minas Gerais","volume":"19","author":"P\u00f4rto","year":"2019","journal-title":"Case Rep Dermatol Med."},{"key":"10.1016\/j.abd.2023.01.006_bib0050","first-page":"765","article-title":"Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature","volume":"8","author":"Fabi","year":"2009","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.abd.2023.01.006_bib0055","first-page":"67","article-title":"Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction","volume":"104","author":"Petiti-Martin","year":"2013","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.abd.2023.01.006_bib0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.47276\/lr.79.2.193","article-title":"A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide","volume":"79","author":"Vetrichevvel","year":"2008","journal-title":"Lepr Rev."},{"key":"10.1016\/j.abd.2023.01.006_bib0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09546630701386993","article-title":"Thalidomide: an experience in therapeutic outcome and adverse reactions","volume":"18","author":"Sharma","year":"2007","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.abd.2023.01.006_bib0070","doi-asserted-by":"crossref","first-page":"35776","DOI":"10.18632\/oncotarget.16205","article-title":"An absence of platelet activation following thalidomide treatment in vitro or in vivo","volume":"8","author":"Qiao","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.abd.2023.01.006_bib0075","first-page":"30","article-title":"Anti-\u03b22-glycoprotein I antibodies are highly prevalent in a large number of Brazilian leprosy patients","volume":"36","author":"Ribeiro","year":"2011","journal-title":"Acta Reumatol Port."},{"key":"10.1016\/j.abd.2023.01.006_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/0037-8682-0216-2017","article-title":"Anti-phospholipid syndrome in seven leprosy patients with thrombotic events on corticosteroid and\/or thalidomide regimen: insights on genetic and laboratory profiles","volume":"51","author":"Vernal","year":"2018","journal-title":"Rev Soc Bras Med Trop."},{"key":"10.1016\/j.abd.2023.01.006_bib0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s42358-019-0094-4","article-title":"Epidemiological, clinical and immune factors that influence the persistence of antiphospholipid antibodies in leprosy","volume":"59","author":"Ribeiro","year":"2019","journal-title":"Adv Rheumatol."},{"key":"10.1016\/j.abd.2023.01.006_bib0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11239-007-0057-1","article-title":"Arterial thrombosis and thalidomide","volume":"25","author":"Goz","year":"2008","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.abd.2023.01.006_bib0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10245330290020126","article-title":"Thromboembolism in patients on thalidomide for myeloma","volume":"7","author":"Bowcock","year":"2002","journal-title":"Hematology."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059623001939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059623001939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:42:25Z","timestamp":1759794145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059623001939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0365059623001939"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2023.01.006","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2023.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}